PHI-101

• Description :

  PHI-101 is an orally available and selective checkpoint kinase 2 (Chk2) inhibitor for the study of refractory acute myelogenous leukemia (AML) and ovarian cancer.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  386.44

• Molecular Formula :

  C19H19FN4O2S

• Notes :

  Research use only, not for human use.

• Receptor :

  Chk

• CAS Number :

  2127107-15-5